Table 2.
Reason | Radiotherapy (n = 28) |
Chemotherapy (n = 64) |
Surgery (n = 21) |
Overall* |
||||
---|---|---|---|---|---|---|---|---|
No. of Patients | % | No. of Patients | % | No. of Patients | % | No. of Patients | % | |
Physician decision | 8 | 29 | 34 | 53 | 4 | 19 | 37 | 39 |
Technical factors | 8 | 29 | 5 | 7 | 3 | 14 | 21 | 22 |
Patient decision | 2 | 7 | 1 | 2 | 3 | 14 | 3 | 3 |
Change in ECOG PS/progressive disease | 1 | 3 | 7 | 11 | 0 | 0 | 9 | 9 |
Lung comorbidity | 4 | 14 | 7 | 11 | 7 | 34 | 13 | 14 |
Other comorbidity | 3 | 11 | 9 | 14 | 4 | 19 | 11 | 11 |
Alternate modality | 2 | 7 | 1 | 2 | 0 | 0 | 2 | 2 |
Abbreviations: MDM, multidisciplinary meeting; ECOG PS, Eastern Cooperative Oncology Group performance status.
The overall patient numbers do not represent the sum of patient numbers for each treatment, as an individual patient could appear in more than one treatment column if multimodality treatment was the optimal treatment.